Profitability
Weight: 20%
D
36
- 5yr Avg ROIC 8.3%
- Operating Margin Trend -63.94 pp/yr
MRNA
Moderna, Inc.
AlphaQuality composite grade, weighted for stable earnings power businesses.
⚠ 3 of the last 5 fiscal years showed negative net income — AlphaQuality will not grade above F for persistent unprofitability in a stable earnings power business.
Grade overrides the 30.0 pillar composite — hard gates always win.
Capital Efficiency
Weight: 15%
C-
46
- 5yr Avg ROE 6.1%
- 5yr Share-Count CAGR 0.4%
Growth Quality
Weight: 15%
A-
81
- 5yr Revenue CAGR 19.3%
- Revenue-Growth Years (5) 2/5
Cash Generation
Weight: 15%
D
37
- 5yr FCF Margin -37.9%
- 5yr FCF/NI Conversion 0.82x
Balance Sheet
Weight: 20%
F
25
- Net Debt / EBITDA 10.00x
- Interest Coverage (EBIT/Int) -276.80x
- Altman Z-Score 9.37
Stability
Weight: 15%
D
36
- Negative-Revenue Years (5) 3/5
- Piotroski F-Score 3
Guru Flow
Curated superinvestor sentiment — not part of the AlphaQuality grade.3 of 3 gurus held; 1 added; 2 trimmed; 1 full exit.
- Holders
- 3
- Avg Δ position
- -47.0%
- New buys
- 0
- Full exits
- 1
- Greenblatt sold -100%
- Cooperman decreased -96%
- Dalio decreased -85%